Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MRK
MRK logo

MRK News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

MRK News

Merck Unveils Novel Oral PCSK9 Inhibitor Enlicitide

2d agoNewsfilter

Equity Markets Steady Amid Uncertainty; Quality Dividend Stocks Attract Investors

1d agoFool

Doceree Launches New System for Pharma Brand Teams

2d agoYahoo Finance

Eli Lilly's Mounjaro Becomes World's Best-Selling Drug

2d agoFool

Analyst Raises Merck Price Target to $112 After Q1 Beat

3d agoYahoo Finance

Salesforce and Merck Collaborate on Unified Customer Platform

3d agoseekingalpha

Analysts Predict Market Returns for the Next Decade

4d agoFool

Comparative Income Outlook for Philip Morris and Altria

4d agoNASDAQ.COM

MRK Events

05/06 09:10
Merck Animal Health Selects Salesforce to Enhance Customer Engagement
Salesforce (CRM) and Merck Animal Health (MRK) announced that Merck Animal Health has selected Agentforce Life Sciences for Customer Engagement to create a unified, 360-degree view and support experience for veterinarians, pet owners, and production animal farmers across all channels. "At Merck Animal Health, we support the strong bond between people and their pets and help protect international public health, ensure food safety, and increase protein supply. Using Salesforce's Agentforce Life Sciences as our 'OneCRM,' we will reimagine the way we engage with our veterinarians, pet owners, production animal farmers, and the animals under their care." - Juanjo Francesch, VP, Animal Health IT, Merck Animal Health
05/05 16:40
Major U.S. Averages Close Broadly Higher, Nasdaq Up 1.03%
The major averages closed broadly higher as oil pulled back, though the ceasefire between the U.S. and Iran continues to be fragile. However, U.S. Defense Secretary Pete Hegseth said the ceasefire "certainly holds" and claimed that two U.S. commercial ships have already "safely transited the strait, showing the lane is clear."Meanwhile, earnings remain strong and AI capital expenditures continue to act as a structural tailwind. There is persistent capital flow into semis and hyperscalers, with expectations for massive multi-year spend cycles anchoring estimates higher.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Palantirprovided areport for Q1PayPalreportedand provided its outlook for Q2 and FY26Coinbaseannounced plans to, or 700 employeesPfizerreportedand reiterated its FY26 guidancePinterestreportedand provided Q2 revenue guidance2. WALL STREET CALLS:Ulta Beautyto Buy at BofA on improved earnings flywheelRobloxto Neutral at Piper Sandler on lack of visibilityArgusChipotleto Buy, expects comp growth to accelerateStephensRepay Holdings, sees "two binary outcomes"Tractor Supplyto Neutral at Piper Sandler3. AROUND THE WEB:FDA officials have blocked publication of several studies supporting the safety of widely used vaccines against Covid-19 and shingles in recent months, NY Times reportsHondaplans to shelve its $11B Canada EV plant as demand sputters, Nikkei reportsNissanis planning to cut roughly 10% of its European workforce and consolidate production lines at its Sunderland Plant as part of a broader restructuring effort, while exploring partnerships such as with Chery to utilize excess capacity and improve financial performance, FT saysBerkshirehas selected Gen Re chairman Charlie Shamieh to succeed Ajit Jain, Vice Chairman of Insurance Operations, when Jain decides to retire, Bloomberg reportsAppleis planning to release a new "Create a Pass' feature for its next iPhone software update, which will allow users to build and customize their digital tickets and gift cards in the Wallet app, Bloomberg says4. MOVERS:Backblazehigher afterand raising its guidance for FY26EverQuote, Digital Oceanand BRC Inc.increase afterDigi Power Xgains after signing aGeneDxlower afterand lowered its guidance for FY26BellRing Brandsand Adtranfalls after5. EARNINGS/GUIDANCE:Portillo's, with EPS and revenue missing consensusIPG Photonicsand provided guidance for Q2, with CEO Mark Gitin commenting, "I am pleased to share that first-quarter revenue came in above our expectations"Neuroneticsand backed its guidance for FY26Surgery Partnersand backed its guidance for FY26, with CEO Eric Evans commenting, "We are encouraged by our solid start to 2026"Expeditors, with EPS and revenue beating consensusINDEXES:The Dow rose 356.35, or 0.73%, to 49,298.25, the Nasdaq gained 258.33, or 1.03%, to 25,326.13, and the S&P 500 advanced 58.47, or 0.81%, to 7,259.22.

MRK Monitor News

Merck Reports Strong Q1 Results Driven by Keytruda Demand

Apr 30 2026

Merck's Late-Stage Trial with Eisai Fails to Meet Goals

Apr 21 2026

Merck's Keytruda Approved in EU; Analyst Upgrades Price Target

Apr 08 2026

Merck's KEYTRUDA and WELIREG Show Positive Phase 3 Results in Kidney Cancer

Mar 05 2026

Merck's KEYTRUDA Receives FDA Approval for Ovarian Cancer

Feb 13 2026

Merck Reports Strong Q4 2025 Results with Key Product Growth

Feb 05 2026

Merck Reports Strong Q4 2025 Results with Key Product Growth

Feb 04 2026

Merck Declares $0.85 Dividend, Reflecting Financial Health

Feb 02 2026

MRK Earnings Analysis

No Data

No Data

People Also Watch